Entities / Company
Rallybio.
American biotechnology company
- Reports this week
- 0
- Active events
- 1
- Connections
- 13
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Active this week
One to three months ago
Gone quiet
No new reports in 90+ days-
Recursion Pharmaceuticals acquired Rallybio's joint venture stake.Some support5 reports
-
Jon Lieber was appointed to the Board of Directors of ImmunoPrecise Antibodies Ltd. on July 7, 2025.Speculative1 report
-
Rallybio and Recursion initiated preclinical studies for the compound REV102.Some support2 reports
No events began in the chosen period. Widen it, or reset.
Around Rallybio this week
News at the entities that move Rallybio most-
New Haven Shared contextCoastal flooding is possible in Fairfield and New Haven counties, while Middlesex counties face high wind warnings.Moves Rallybio
Connections
The 2 strongest of 13, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Standard BioTools Inc. Mentioned together
Both companies are currently involved in merger investigations.
-
New Haven Shared context
Rallybio is headquartered and operates from New Haven, Connecticut.
History
Events by the month they beganJuly 2026
1 eventJune 2026
4 events- Trump's oil and gas pledges benefit US stocks, specifically impacting Pfizer.
- Recursion Pharmaceuticals acquired Rallybio's joint venture stake.
- Jon Lieber was appointed to the Board of Directors of ImmunoPrecise Antibodies Ltd. on July 7, 2025.
- Rallybio and Recursion initiated preclinical studies for the compound REV102.